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Summary 
Vetsuisse-Fakultät Universität Zürich (2015) 
 
Claudia Tritschler 
 
Departement für Kleintiermedizin, Vetsuisse-Fakultät Universität Zürich 
claudia.tritschler@gmx.ch  
 
 
Increased Erythrocytic Osmotic Fragility in Anemic Domestic Shorthair and 
Purebred Cats 
 
 
Objectives: Increased osmotic fragility and splenomegaly were reported in anemic 
Abyssinian and Somali cats. Here we report about this condition in domestic shorthair 
cats and two other breeds. 
Methods: The osmotic fragility test was performed, known causes of anemia were 
excluded, the illness was followed, and medical records were reviewed. 
Results: Twelve cats were first found to be anemic between 0.5-9 years of age. 
Pallor, lethargy, inappetence, pica, weight loss and splenomegaly were commonly 
observed. A macrocytic and hypochromic anemia with variable regeneration was 
noted. Infectious disease screening, direct Coombs’, and pyruvate kinase DNA 
mutation test results were negative. Freshly drawn blood did not appear hemolyzed 
but became progressively lyzed during storage. The sigmoid osmotic fragility curves 
were right shifted and cross-correction studies indicated a red cell effect.  
Most cats were treated with prednisolone and doxycycline. Five cats with recurrent or 
persistent anemia responded well to splenectomy. However, two had occasional 
recurrence of severe anemia. Finally, six cats were euthanized within 1 month and 7 
years after initial presentation. Histopathology of 6 spleens revealed mainly 
congestion and extramedullary hematopoiesis. 
Conclusion: Similar to Abyssinians and Somalis, domestic shorthair cats and other 
breeds can also develop osmotic fragility with anemia and splenomegaly, which 
should be considered as a differential diagnosis in anemic cats. 
 
Key words: hemolytic anemia, in vitro lysis, erythrocyte membrane abnormality, 
splenomegaly, cross-correction 
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Zusammenfassung 
Vetsuisse-Fakultät Universität Zürich (2015) 
 
Claudia Tritschler 
 
Departement für Kleintiermedizin, Vetsuisse-Fakultät Universität Zürich 
claudia.tritschler@gmx.ch 
 
 
Erhöhte Erythrozytäre Osmotische Fragilität bei Anämischen Haus- und 
Rassekatzen 
 
 
Ziele: Erhöhte osmotische Fragilität und Splenomegalie wurden bei anämischen 
Abessinier- und Somalikatzen beschrieben. Hier beschreiben wir diese Erkrankung 
bei Haus- und zwei weiteren Rassekatzen. 
Methoden: Die osmotische Fragilität wurde getestet, bekannte Anämieursachen 
ausgeschlossen, der Verlauf verfolgt und Krankheitsgeschichten überprüft. 
Resultate: Anämie wurde bei zwölf Katzen erstmals mit 0,5-9 Jahren diagnostiziert. 
Blässe, Lethargie, Appetitlosigkeit, Pica, Gewichtsverlust und Splenomegalie waren 
häufige Symptome. Charakteristika der Anämie waren Makrozytose, Hypochromie 
und variable Regeneration. Infektionskrankheiten, direkter Coombs und 
Pyruvatkinase-Mutations-Test fielen negativ aus. Frisches Blut erschien normal, 
hämolysierte aber während der Lagerung. Die sigmoidalen osmotischen 
Fragilitätskurven waren nach rechts verschoben und Kreutz-Korrektur-Studien 
deuteten auf ein Erythrozytenproblem. 
Die meisten Katzen wurden mit Prednisolon und Doxyzyclin behandelt. Fünf Katzen 
mit rezidivierender oder persistierender Anämie sprachen gut auf Splenektomie an. 
Zwei davon zeigten aber später Rezidive. Sechs Katzen wurden zwischen 1 Monat 
bis 7 Jahre nach der ersten Präsentation euthanasiert. Histopathologie von 6 Milzen 
zeigte Kongestion und extramedulläre Hämatopoese. 
Konklusion: Wie auch Abessinier und Somalis können Hauskatzen und andere 
Rassen osmotische Fragilität mit Anämie und Splenomegalie entwickeln, was als 
Differentialdiagnose berücksichtigt werden sollte. 
 
Schlüsselwörter: Hämolytische Anämie, In-vitro-Lyse, Erythrozytenmembran-
Abnormalität, Splenomegalie, Kreuz-Korrektur   
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Introduction 
 The erythrocytic osmotic fragility (OF) test estimates the surface area to volume 
ratio of erythrocytes and is used to measure red blood cell (RBC) fragility in cases of 
chronic or recurring anemia.1 Briefly, whole blood is incubated in isotonic to hypotonic 
sodium chloride (NaCl) solutions at 20°C. As water is drawn into RBCs during exposure 
to progressively hypotonic solutions, the RBCs swell, leak and then burst. The 
hemoglobin (Hb) released into the supernatant is assessed spectrophotometrically and 
is expressed as percentage of the completely lyzed blood in distilled water. The normal 
OF curve is sigmoid, and the mean osmotic fragility (MOF; NaCl concentration at which 
50% of RBC lyzed) occurs around 0.5% NaCl in healthy animals. Generally, the OF is 
inversely related to the normal size of RBCs in animal species.2 
 In humans, an abnormal erythrocytic OF test result may suggest hereditary RBC 
membrane defects such as spherocytosis and stomatocytosis,3 but is also observed 
with some acquired disorders such as renal failure, diabetes mellitus, and immune-
mediated hemolytic anemia (IMHA).1,3 Nowadays, the OF test is rarely conducted in 
human medicine and has been replaced by more specific tests, such as ektacytometry, 
protein electrophoresis, Coombs’ test, and DNA tests for hereditary RBC membrane 
defects.3 Increased OF was also reported in dogs with hereditary spectrin deficiency,4,5 
hereditary stomatocytosis,5-9 IMHA10,11 and other anemias.12 
 Increased OF has also been documented in cats with IMHA,13 and in Abyssinian 
and Somali cats, which may have a hereditary erythrocyte membrane defect.14 In the 
latter, fragile RBCs were accompanied by chronic intermittent hemolytic, macrocytic-
hypochromic and variably regenerative anemia, splenomegaly, hyperglobulinemia, 
lymphocytosis, hyperbilirubinemia, and increased serum hepatic enzyme activities. 
Here we report on increased erythrocytic OF in anemic domestic shorthair (DSH) cats 
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and other purebred cats with clinicopathological features similar to that previously 
reported in Somali and Abyssinian cats. 
Material and Methods 
Animals and Samples 
 Client-owned cats other than Abyssinians and Somalis that were diagnosed with 
chronic or intermittent anemia of unknown cause, had negative infectious disease 
screening and direct Coombs’ test results by the primary or referring veterinarian, and 
which revealed increased fragility in a requested erythrocytic OF test by the PennGen 
Laboratory (PennGen, University of Pennsylvania, School of Veterinary Medicine, 
Philadelphia, PA) between September 2009 and September 2014, were included. 
Fresh ethylenediaminetetraacetate (EDTA) anticoagulated blood samples (2-4 ml) 
were either collected at the Ryan Veterinary Hospital (University of Pennsylvania, 
Philadelphia, PA), or submitted by the referring veterinarian along with a sample from 
a healthy cat (frequently a donor cat that needed blood typing or other screening tests) 
by overnight shipping. Additional control blood samples were obtained from healthy 
cats from a research colony at the University of Pennsylvania. All samples were sent 
and kept refrigerated at 4°C and analyzed simultaneously the same and/or the 
following day. The study was performed according to the Guidelines for the Institutional 
Care and Use of Animals in Research. 
 Signalment and medical records including history, physical examination, 
clinicopathological information and therapeutic interventions taken at the first diagnosis 
of anemia were reviewed. Cats were followed after initial diagnosis of increased OF 
when possible. 
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Laboratory Tests 
 Routine laboratory tests utilized for this analysis, including complete blood count 
(CBC), reticulocyte count, packed cell volume (PCV), total protein (TP), microscopic 
blood smear evaluation, serum chemistry panel, and urinalysis, were performed at the 
same time or shortly before the first OF test. All of these tests were performed either 
by the primary clinic, their reference laboratories (IDEXX, Westbrook, ME or Antech, 
Irvine, CA) or the clinical laboratory of the Ryan Veterinary Hospital. 
 A direct Coombs’ test was performed at 37°C using regular commercial reagents 
(IgG, IgM, C3), by the reference laboratory utilized by the submitting clinic and follow 
up tests also by PennGen (Antiglobulin Feline Test, Alvedia, Limonest, France) at 
20°C, which has not yet been independently validated. Similarly, feline blood typing15 
and pyruvate kinase (PK) deficiency DNA testing15,16 was performed at PennGen. 
 All cats were tested for feline leukemia virus (FeLV) antigen and feline 
immunodeficiency virus (FIV) antibodies by SNAP test (IDEXX) and hemoplasma PCR 
(M. haemofelis, M haemominutum, M. turicensis). Other infectious disease screening 
tests (NCSU, Vector Borne Disease Lab, Raleigh, NC) performed in some cats 
included antibody screening for Bartonella species using an immunofluorescence 
assay and/or Western blot (National Veterinary Laboratory, Franklin Lakes, NJ) and 
PCR testing for Anaplasma, Babesia, Bartonella, Ehrlichia, Hemoplasma, Rickettsia, 
and Cytauxzoon species. 
 
Abdominal Imaging, Histopathology and Cytology  
 Abdominal imaging studies were evaluated when performed. Gross and 
histopathological or cytological findings of the spleen, liver, and bone marrow were 
reviewed, when necropsied, removed, biopsied and/or aspirated. 
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Erythrocytic In Vitro Lysis and Osmotic Fragility Test 
 The PCV, whole blood and plasma Hb concentrations were measured (B-
Hemoglobin HemoCue, Ängelholm, Sweden)17 to assess in vivo and in vitro lysis of 
samples at the time of receipt (freshly drawn or after shipping overnight chilled) and 
again the next day after storage at 4°C. 
 The OF test was performed as previously described by this laboratory10,14 with 
minor modifications from the original assay.18 Anticoagulated blood from patients and 
corresponding healthy control cats were processed simultaneously. Briefly, a series of 
phosphate buffered NaCl dilutions was prepared, containing concentrations of 0.85, 
0.8, 0.75, 0.7, 0.65, 0.6, 0.55, 0.5, 0.45, 0.4, 0.35, 0.25 and 0% NaCl. Two milliliters of 
each solution were mixed well with 15 µl of whole blood in individual test tubes. After 
30-45 minutes of incubation at 20°C, samples were centrifuged at 2000 g for 10 
minutes. The optical densities of the supernatants were measured 
spectrophotometrically at 540 nm and the percentage of hemolysis of each tube was 
calculated. The MOF was determined from the obtained lysis curve. 
 
Cross-Correction Testing 
 In order to differentiate between intrinsic (RBC) and extrinsic (plasma) issues, 
patient RBCs and plasma were simultaneously incubated separately with the 
reciprocal components from the healthy control cat. Briefly, after centrifuging ~0.5 ml 
EDTA blood at 1000 g for 3 minutes, the plasma was transferred into another tube, 
while the RBCs were suspended in 1 ml phosphate buffered saline (PBS) and then 
again centrifuged. Washing with PBS was repeated twice to remove all plasma. 
 An aliquot (~0.2 ml) of washed RBCs from the affected and its healthy control cat 
were then incubated at 4°C with an aliquot (0.2-0.3 ml) of plasma from the control cat 
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and from the affected cat, respectively. After 6 and 24 hours incubation, OF tests were 
performed with both sample combinations and the unwashed original blood samples 
at 20°C. 
 
Analysis and Statistics 
 Following data acquisition by Excel 2013 (Microsoft Corporation, Redmond, WA) 
standard statistical analyses were applied (IBM SPSS Statistics 22, IBM, Armonk, NY). 
Data was tested for normal distribution with the Kolmogorov-Smirnow-test. Normally 
distributed parametric data was illustrated as mean ± standard deviation (m ± SD) and 
non-normally distributed data as median and range. The Wilcoxon Signed Rank test 
was performed to test the paired MOF results, from affected and control cats in OF 
testing and the cross-correction studies. Probability values of p<0.05 were considered 
statistically significant. 
Results 
Animals 
 In total, 12 cats (Table 1) including ten DSH cats, one Ocicat and one Siamese cat, 
all neutered and privately owned in different parts of the United States, exhibiting 
chronic or intermittent anemia and increased erythrocytic OF were included in this 
study. Nine DSH cats were adopted from shelters or found as stray cats, while the 
others (cat 2, 3 and 7) were obtained from breeders. All cats were kept indoors, fed a 
commercial cat food, and were never exposed to any known toxins according to the 
owners. Eight animals lived with at least one other cat in the same household, and one 
also with dogs. The cats’ coat colors varied, but four were tricolored, cream diluted 
tabby DSH cats from Southwestern Pennsylvania (Table 1): their estimated birth dates 
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ranged from 2006 to 2011. The Ocicat and one DSH cat (cat 11) had littermates and 
other relatives with anemia of unknown cause according to the owners, but those were 
not further studied.  
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Table 1 Clinical details about cats with increased OF including treatment, additional tests and clinical course 
Cat  Sex 
First 
anemia 
(age in 
years) 
OF tested   
(age in 
years) 
Additional 
infectious disease 
screen ¶ 
Doxy-
cycline 
Predni-
solone 
pRBC n 
events 
Relapses         
post-
medication        
Spleen 
ultrasound 
findings 
Splenectomy 
(age in 
years) 
Relapses                   
post-
splenectomy           
Histopathology 
spleen (S)/ 
Liver (L) 
Current 
Age/Age of 
Death 
(years) 
1 
‡,§ 
F 1.5 2.5 Vector borne 
disease panel √ √ - 
4 in 2 years Mottled, nodules 4.5 0 S 6.75 
2 M 2 2.75 Vector borne 
disease panel √ √ - 
2 in 0.66 
year 
Mottled 2.75 0 S/L 3.25 
3* M 4.25 4.5  
√ √ 1 
No 
improvement 
Not done 4.5 0 S 5.75 
4 
‡,§ 
F 2.25 2.5 Vector borne 
disease panel √ √ - 
1 after 0.5 
year 
Normal 
echotexture 
3 2 after 3 years 
within 0.5 year 
S 6.75 
5 M 2 5.25  
√ √ 1 
2 in 3.25 
years 
Granular 5.25 2 after 2 years 
within 2 years 
S Euthanized            
9 
6 
‡,§ 
F 2 3  
√ √ 1 
2 in 1.25 
year 
Mottled No -  3.5 
7† M 4 4  
- √ - 
None, doing 
well 
Normal 
echotexture 
No -  4.75 
8 
‡,§ 
F 7.5 7.5 Bartonella  
Western blot - √ 2 
1 after 0.75 
year 
Nodules No -  Euthanized            
8.5 
9 F 0.5 0.6 Vector borne 
disease panel √ √ 1 
No 
improvement 
Not done No -  Euthanized            
0.6 
10§ F 9 9 Vector borne 
disease panel √ √ 6 
No 
improvement 
Mottled, nodules No - S/L Euthanized            
9 
11 F 0.5 0.65 Bartonella  
Western blot √ - - 
1 after 0.5 
year 
Not done No - L Euthanized              
1 
12 M 1.5 2 Vector borne 
disease panel √ √ - 
1 after 0.5 
year 
Mottled No -  Euthanized             
2 
* Ocicat, † Siamese, ‡ dilute cream tabby cats, § Cases presented at UPenn, ¶ Vector borne disease panel: PCR for Anaplasma, Babesia, 
Bartonella, Ehrlichia, Hemoplasma, Rickettsia, Cytauxzoon species and immunofluorescence and/or Western blot assay for Bartonella 
species  
F = female; M = male; pRBC = packed RBC transfusion, (√) = medication received or test performed. 
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Clinical Signs and Routine Test Results 
 Pallor (n = 11), lethargy (8) and splenomegaly (11) were the main clinical signs at 
presentation. Weight loss (5), inappetence (6) and pica (5) were additionally observed. 
Three of the dilute colored cats had increased body condition scores (BCS) ranging 
between 6-8 (normal BCS 5/9). One additional DSH cat (cat 2) with black fur also had 
an increased BCS of 8, but none had hyperlipidemia on presentation. First anemia 
was found between 0.5-9 years of age (median: 2.25 years). 
 All cats had a history of chronic or intermittent anemia before the OF test was 
performed (Table 1 and 2). They were found to be anemic with a wide range of 
hematocrits, which also fluctuated greatly over time. Common RBC characteristics at 
the initial time of OF testing were moderate to marked macrocytosis (9), mild 
hypochromasia (5), mild to marked anisocytosis (10; Figure 1), polychromasia (8), and 
reticulocytosis (7) [insert Figure 1]. If these characteristics were not noted initially, they 
were found at later examinations. Moreover, in seven cats, few to many normoblasts 
were seen on blood smear examination. Low or moderate numbers of Heinz bodies 
and Howell Jolly bodies were also found in four and three cats, respectively. 
 Total white blood cell (WBC) counts of 11 cats were in the reference interval (RI), 
except cat 12 (Table 1+2), which had a severe neutrophilia (39.6x103/µl, RI: 2.3-14.0 
x103/µl) with normal cell morphology. Rare reactive lymphocytes were initially 
observed on blood smears of three cats, but were also seen in four additional cats at 
later examinations. 
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Table 2 Selected hematology and chemistry panel results from all 12 cats 
with increased OF at initial examination.  
Parameter (Unit) Mean ± SD      or Median Range 
Reference 
interval 
HCT (%) 20.3 ± 7.1 6.9 – 26.0 31.7 - 48.0 
RBC (x106/µl) 3.4 ± 1.4 1.0 - 5.5 6.6 - 11.2 
Hb (g/dl) 6.31 ± 2.26 2.1 - 9.6 10.6 - 15.6 
MCV (fl) 63.5 ± 12.3 43.0 - 79.0 36.7 - 53.7 
MCHC (g/dl) 30.9 ± 2.6 27.9 - 38.3 30.1 - 35.6 
Reticulocytes (x103/µl) 130 12 - 666 0 - 50 
nRBC (/100 WBC) 3 0 - 126 0 - 1 
WBC (x103/µl) 12.7 4.6 - 40.7 4.0 - 18.7 
Serum bilirubin (mg/dl) 0.6 0.2 - 6.9 0.1 - 0.4 
HCT = hematocrit; Hb = hemoglobin; MCV = mean corpuscular volume; 
MCHC = mean corpuscular hemoglobin concentration; 
nRBC = nucleated red blood cells; WBC = white blood cells 
 
 Urinalysis and serum chemistry results were normal, except five cats had mild and 
cat 12 marked hyperbilirubinemia. Cat 12 also had elevated serum liver enzyme 
activities: alanine aminotransferase (ALT): 401 U/L, RI: 33-152 U/L; aspartate 
aminotransferase (AST): 349 U/L, RI: 1-37 U/L.  
 Serum iron concentrations measured in cat 2 and 4 were normal. Direct Coombs’ 
test and PK deficiency DNA test results were negative in all cats. 
 All animals were negative for FeLV, FIV and Hemoplasma infections. Additionally, 
six cats tested negative for the available entire vector borne feline infectious disease 
panel by PCR and serology and two cats were serologically negative for Bartonella 
species infections by Western blot (Table 1). Cat 4 was later found to be serologically 
strongly positive for Bartonella vinsonii (see below). 
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Abdominal Imaging, Histopathology and Cytology Findings 
 Abdominal ultrasound performed on nine cats showed mild to severe 
splenomegaly with varied changes and three (cat 5, 6, 8) also had mild hepatomegaly 
(Table 1).  
 Histopathological examination (Table 1) of splenic samples from splenectomy (5) 
and necropsy (1) revealed marked congestion (5), mild to moderate extramedullary 
hematopoiesis (5), mild hemosiderosis (3), mild scattered lymphoid follicles (1), and 
scattered clusters of macrophages (2). Hepatic samples from one wedge biopsy and 
two necropsies showed moderate extramedullary hematopoiesis (2), histiocytosis (1) 
and marked hemosiderosis (1). One bone marrow aspirate (cat 10) revealed mild 
erythroid hyperplasia and focal megakaryocytic hyperplasia, while the other seemed 
unremarkable (cat 5). 
 
Erythrocytic In Vitro Lysis and Osmotic Fragility Test Results 
 While no to little hemolysis was observed at the time of blood collection, moderate 
to severe in vitro hemolysis (plasma Hb 0.8-5.5 g/dl) was observed in 8/10 EDTA blood 
samples evaluated after 6 and 24 hours (Figure 2) stored at 4°C. Simultaneously 
handled control blood samples revealed little to no hemolysis (plasma Hb ≤0.3 g/dl) 
based upon visual examination of microhematocrit tubes and plasma Hb 
determinations [insert Figure 2.]. 
 The OF curves of the anemic cats were moderately to severely right shifted (Figure 
3), with MOF`s ranging from 0.63-0.87% NaCl at the time of initial testing, when 
compared to corresponding controls, for which the MOF`s ranged from 0.45-0.57% 
NaCl (p=0.002). The location and shape of the OF curve either stayed as initially 
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determined or the RBCs became even more fragile after 24 hours. In two cases (cat 
3 and 10) only a small proportion of RBCs resisted storage at 4°C one day after blood 
collection, making OF testing nearly impossible [insert Figure 3.]. 
 
Cross-Correction Test Results 
 Plasma and washed RBC components of blood samples from three DSH cats (cats 
4, 6, 11) were cross-corrected with components of their complementary control blood 
samples. In all three cases MOFs of RBCs from healthy control cats remained normal 
after incubation at 4°C with either their own plasma or plasma from the affected cats. 
In contrast, MOFs of RBCs from affected cats remained increased after incubation 
with either their own plasma or plasma from the control cats (Table 3). Thus, an 
intrinsic issue causing increased erythrocytic OF is suspected. 
 
Table 3 Osmotic fragility of erythrocytes in in vitro cross-correction experiments. 
MOF’s (%) of cross-correction test results from three cats expressed as median 
(range) 
Incubation Patient RBCs Control RBCs 
(Hours) + Patient Plasma + Control Plasma + Control Plasma + Patient Plasma 
0 0.65 (0.65-0.83) - 0.54 (0.51-0.57) - 
6 0.65 (0.64-0.73) 0.62 (0.59-0.75) 0.55 (0.51-0.55) 0.52 (0.50-0.54) 
24 0.66 (0.65-0.76) 0.67 (0.61-0.75) 0.55 (0.52-0.57) 0.53 (0.51-0.59) 
 
Therapy and Follow-up Results 
 All cats were initially treated with doxycycline and/or immunosuppressive doses of 
prednisolone (1-2 mg/kg BID) presumptively for an infectious and/or immune process 
except for cat 8 (Table 1). Generally, when the PCV rose the prednisolone dose was 
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tapered stepwise every 2-4 weeks until withdrawn. Cats with persistent or recurring 
anemia according to follow-up routine laboratory results, were continually treated or 
retreated with prednisolone (1-2 mg/kg BID), splenectomized and/or euthanized. In 
critically ill cases of severe anemia, AB type compatible packed RBCs were transfused 
(Table 1). Few cats also received additional antibiotics, including amoxicillin/clavulanic 
acid (4), enrofloxacin (2), marbofloxacin (1), and azithromycin (1). 
 Of the five splenectomyzed cats, three recovered without relapse and recent follow 
up OF tests were normal in these cats. Cat 4 (Table 1; Figure 4) had an episode of 
recurrent anemia with abnormal OF 3 years after splenectomy and was found to be 
serologically positive for B vinsonii, but was negative by PCR test. Rapid improvement 
was observed after treatment with azithromycin and prednisolone. PCR test results for 
Bartonella species remained negative, and the serum antibody titer against B vinsonii 
declined drastically over 5 months to negative. However, this cat relapsed 6 months 
later with severe anemia (PCV 16%) and increased OF, but was completely negative 
for any infectious diseases and recovered well following prednisolone and 
azithromycin treatment (PCV 35% for past 8 months) [insert Figure 4.]. 
 Cat 5 developed recurrent anemia of unknown cause 2 years after splenectomy, 
which appeared to respond well to intermittent prednisolone therapy for another 2 
years, but the cat was then euthanized. 
 Special cases that did poorly and were not splenectomized are presented below: 
 Cat 8 was found to have macrocytic anemia on a routine exam and aside from 
routine blood work and the OF test, additional diagnostics and treatments were 
declined by the owner. However, 9 months later this cat developed severe anemia 
(PCV 9%). No cause was identified and medical emergency treatment appeared 
unsuccessful and the cat was euthanized. 
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 Cat 11 was stable for 7 months with mild anemia (PCV 26%) before developing 
suddenly severe hyperbilirubinemia (from 20.1 to 25.5 mg/dl; PCV 21%) and mildly 
increased serum ALT activities (from 199 to 225 U/L) that appeared therapeutically 
unresponsive to routine emergency care. Necropsy revealed cholangiohepatitis with 
cholestasis, fibrosis and centrolobular atrophy.  
 Cat 12 showed intermittent recurring anemia over 6 months, then acutely 
developed non-regenerative anemia, neutrophilia, hypoproteinemia and also had 
elevated serum ALT activity (401 U/L) and was euthanized. No necropsy was 
performed. 
Discussion 
 Anemia is a very common abnormality in cats in any clinical practice and can result 
from infectious, immune, toxic, metabolic and inherited causes.19,20 Here we describe 
a unique condition of anemia with increased erythrocytic OF and splenomegaly in DSH 
and purebred cats similar to what this laboratory previously described in anemic 
Abyssinian and Somali cats.5,14 Prevalence and underlying cause(s) still need to be 
determined. 
 A remarkably severe in vitro fragility of erythrocytes that is not typically observed 
in either feline anemia or other diseases was documented in these 12 anemic cats. 
While hemolysis was not observed in freshly collected blood, it became apparent and 
progressively increased within hours to days of regular storage in an EDTA tube at 
4°C. This was readily evident by visual examination of the EDTA tube and/or after 
centrifuging a blood sample in a microhematocrit tube and without rewarming the 
blood. In fact some blood samples were nearly completely lyzed by the next day, 
whereas the simultaneously handled, shipped, and stored control samples from 
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healthy cats showed little to no hemolysis during the same time frame. Such in vitro 
hemolysis seems to be unique to these cats and the previously reported Abyssinian 
and Somali cats with increased OF.5,14 
 Concordantly, utilization of a classic OF test demonstrated that erythrocytes from 
these cats were markedly more fragile in hypotonic solutions than were RBCs from 
healthy control cats. In fact some erythrocytes started to lyze near physiological NaCl 
concentration. The OF curve was significantly shifted to the right, suggesting that all 
of the erythrocytes were similarly affected. They appeared to swell rapidly even in 
solutions utilized for automated hematology cell counters, resulting in increased 
macrocytic and lyzing artifacts observed during analysis. These observations are 
similar to those reported previously in Abyssinian and Somali cats.14 
 When examining the patients’ erythrocytes and plasma separately in in vitro cross-
correction experiments from three anemic cats compared to controls, it became 
evident that the patients’ washed erythrocytes lyzed similarly in the presence of control 
and autologous plasma, while the controls’ erythrocytes remained stable in autologous 
and patient plasma. These limited data support an intrinsic RBC-related defect, and 
inherited or acquired erythrocyte abnormalities are suspected, but further studies are 
needed. Severely increased OF has been observed in Miniature and Middle 
Schnauzers, Alaskan Malamutes and Drentse Patrijshond with hereditary 
stomatocytosis, a disease assumed to be caused by a red cell membrane defect.6-9 
However, the cats in this report and also in the study of Abyssinian and Somali cats 
had few if any stomatocytes, although the observed high MCV was disproportional to 
the degree of reticulocytosis. Milder erythrocytic OF is also seen with IMHA in dogs10-
12 but has rarely been studied in cats with IMHA.13 Despite extensive attempts to find 
an acquired cause, no immune, infectious (one exceptional cat was later found to have 
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a Bartonella infection as revealed by positive serology), or toxic cause was identified 
over extended follow up periods similar to the previously described Abyssinian and 
Somali cats.14 And indeed increased erythrocytic osmotic fragility has been previously 
reported in a few cats with immune-mediated hemolytic anemia, hemoplasma 
infection, anemia of inflammatory disease and suspected hereditary 
poikilocytosis.13,14,21-23 We did not find any support for these or other diseases in the 
cats of this report.  We did not specifically prepare and examine the blood for cold 
antibodies and complement. Thus, we cannot entirely exclude cold agglutinin disease, 
cold hemolytic anemia, and paroxysmal cold hemoglobinuria as reported in human 
patients.24 None of the cats had any evidence of massive pigmenturia or peripheral 
cold agglutinin disease. Furthermore, the lyzing observed in vitro at cold temperatures 
and increased OF seem unique to these cats.  
 Interestingly, four of the 12 affected stray cats from Southeastern Pennsylvania 
had a tricolored dilute hair coat, suggesting that perhaps they were related and, 
therefore, had a common hereditary red cell defect. While some cats including three 
of the tricolored cats with dilute hair coat were overweight, their plasma was not found 
to be lipemic during routine laboratory testing. Interestingly, lipemia has been 
associated with increased OF in different species, receiving a high fat diet and also in 
diabetic dogs.25-29 
 Despite the overwhelming in vitro evidence of erythrocytic fragility in the cats of 
this report, the in vivo evidence of hemolysis is indirect. These cats had intermittently 
severe anemia, but reached normal hematocrit values. There was never any evidence 
of blood loss, but some of the cats showed pica, which is a typical sign of blood loss 
with iron or other deficiencies. Based upon the lack of hemoglobinemia and 
hemoglobinuria, an extravascular hemolysis predominantly in the enlarged spleen 
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appears most likely. Hemolysis was suggested by a regenerative macrocytic 
hypochromic anemia with mild hyperbilirubinemia and reticulocytosis. The degree of 
reticulocytosis varied greatly, but was frequently less than what would be expected for 
the severity of the anemia, suggesting transient marrow issues hampering the 
regenerative response in these cats. 
 Most of the cats in this as well as the previous report on Abyssinian and Somali 
cats with increased OF14 had moderate to severe splenomegaly. Diffuse 
splenomegaly in cats is often associated with marked extramedullary hematopoiesis 
and was indeed observed in Abyssinian and Somali cats with increased OF. 
Somewhat surprising, extramedullary hematopoiesis was not a major finding here. 
Splenomegaly can also occur in cats with hemoplasmosis, FeLV infection, and other 
infectious diseases30,31 but tests and histopathology did not reveal any infectious 
agents. Similarly, despite an association of anemia with hemolymphatic neoplasias in 
cats30,31 there was no evidence of cancer identified. Splenectomy in five cats with 
severe episodes of anemia seemed to reduce the degree of in vitro lysis and anemia 
for months to years suggesting that the spleen enhanced RBC fragility through an 
unknown mechanism, thereby accelerating RBC clearance. An improved osmotic 
fragility was also observed in cats with hemoplasma infection following splenectomy.32 
 Treatment of cats with immunosuppressive doses of prednisolone appeared to 
temporarily resolve or improve their anemia. As direct Coombs’ tests were all negative, 
prednisolone-mediated inhibition of RBC-specific autoantibodies is unlikely to account 
for the response. However, prednisolone may inhibit macrophage-mediated attack of 
altered RBCs and stabilize membranes.20  
 The ultimate reasons for euthanasia of six cats in this study were lack of response 
to medical treatment and progressive decline or development of hemolytic crisis, 
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severe icterus or recurring anemia. Interestingly, two cats with signs of hemolytic 
anemia signs also showed signs of severe primary hepatopathy and were euthanized. 
It is unclear at this time if the hepatopathy was related to OF in these two cats. No 
bilirubin calculi were found in any cats with increased OF, while in cats with PK 
deficiency it was occasionally observed.33,34 
Conclusions 
 Anemic DSH and other purebred cats can develop severe OF and splenomegaly. 
The RBCs appeared to be extremely fragile in vitro and limited cross correction studies 
support an intrinsic RBC defect in promoting increased erythrocytic OF. Many of the 
observed clinicopathological and histopathological features resemble those previously 
reported in Abyssinian and Somali cats. No acquired, immune, infectious or toxic 
causes could be identified. Treatment with doxycycline, prednisolone, and blood 
transfusions may improve the clinical condition, but such responses appear transient. 
Splenectomy seems to be most effective for long-term improvement of anemia and 
OF, although a cure has not been achieved. 
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Figures 
Figure 1 Blood smears from two cats with increased OF showing anisocytosis (a, b) 
and polychromasia (a). Bar 6µm. 
 
 
Figure 2 Microhematocrits from one cat at time of blood collection and 6 and 24 
hours after blood collection stored at 4°C. PCV’s decreased from 20% to 14% and 
12%, respectively.  
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Figure 3 Osmotic fragility test results from an affected and control cat. An Osmotic 
fragility tube test result with the MOF is depicted with an arrow (a). 
Right shifted curve of an affected cat with increased OF and a normal curve from the 
corresponding control cat (b). The curve of the control cat has a sigmoid shape, 
while the affected cat’s curve is flattened and hemolysis is occurring in higher NaCl 
concentrations. Dashed lines indicate in both curves the MOFs at 50% hemolysis. 
 
 
Figure 4 Clinical course in a cat with increased OF. Hematocrit and reticulocyte 
counts over a 4 year period following first OF testing. 
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